Corient Private Wealth LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1948780 MIAMI, FL

Position in KRYS

as of Jun 30, 2026 · filed Aug 27, 2026 Compact

Position Value

$11,357,491

+$10,447,430 QoQ

Shares Held

30,558

+767.4% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $248,200,388 across 122 Biotechnology names. KRYS ranks #4 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	103,755	$51,538,220
2	IONS	Ionis Pharmaceuticals Inc	196,661	$15,593,250
3	HALO	Halozyme Therapeutics, Inc.	187,166	$14,649,482
4	KRYS	Krystal Biotech, Inc. This page	30,558	$11,357,491
5	TECH	BIO-TECHNE Corp	119,590	$8,449,033
6	REGN	Regeneron Pharmaceuticals, Inc.	12,473	$7,777,414
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,969	$7,215,387
8	CLDX	Celldex Therapeutics, Inc.	176,956	$6,584,532

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,357,491	30,558	+767.4%	Shares	Sole	2026-08-27
2026-03-31	$910,061	3,523	-90.8%	Shares	Sole	2026-05-15
2025-12-31	$9,453,822	38,346	-2.0%	Shares	Sole	2026-03-09
2025-09-30	$6,907,618	39,130	-3.5%	Shares	Other	2025-11-14
2025-06-30	$5,572,353	40,538	-3.8%	Shares	Sole	2025-09-26
2025-03-31	$7,595,498	42,127	-2.1%	Shares	Sole	2025-05-14
2024-12-31	$6,737,789	43,009	-9.8%	Shares	Sole	2025-02-10
2024-09-30	$8,680,464	47,687	-26.6%	Shares	Sole	2024-11-12
2024-06-30	$11,936,599	65,000	+80.7%	Shares	Defined	2024-08-13
2024-03-31	$6,400,497	35,972	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.